(2026). Researchers Submit Patent Application, "Gastroretentive dosage form for prolonged drug delivery", for Approval (USPTO 20260183231). Pharma Business Week, 2442.
Chicago Style (17th ed.) Citation"Researchers Submit Patent Application, "Gastroretentive Dosage Form for Prolonged Drug Delivery", for Approval (USPTO 20260183231)." Pharma Business Week 2026: 2442.
MLA (9th ed.) Citation"Researchers Submit Patent Application, "Gastroretentive Dosage Form for Prolonged Drug Delivery", for Approval (USPTO 20260183231)." Pharma Business Week, 2026, p. 2442.
Warning: These citations may not always be 100% accurate.
